S Saxena, L Durgam, L Guruprasad - Journal of Biomolecular …, 2019 - Taylor & Francis
Development of new antimalarial drugs continues to be of huge importance because of the resistance of malarial parasite towards currently used drugs. Due to the reliance of parasite …
In the present study, we attempted to develop novel class of Mycobacterium tuberculosis (Mtb) inhibitors by exploring the pharmaceutically underexploited enzyme targets which are …
Mycobacterium tuberculosis glutamate racemase is an essential enzyme involved in peptidoglycan synthesis and conserved in most bacteria. Small molecule inhibitors were …
B Saha, A Das, K Jangid, A Kumar, V Kumar… - Current Research in …, 2024 - Elsevier
Alzheimer's disease (AD) leads to gradual memory loss including other compromised cognitive abilities. Acetylcholinesterase (AChE), an important biochemical enzyme from the …
MY Lone, SP Kumar, M Athar, PC Jha - Journal of Theoretical Biology, 2018 - Elsevier
Pharmacophore approaches are of central contour in drug discovery. However, the dependence of ligand–based pharmacophore model on appropriate training set molecules …
Background: Tuberculosis is well-known airborne disease caused by Mycobacterium tuberculosis. Available treatment regimen was unsuccessful in eradicating the deaths …
SM Alladi - Current topics in medicinal chemistry, 2018 - ingentaconnect.com
Tuberculosis continues to remain as one of the leading causes of death worldwide, in spite of significant progress being made in the last twenty years through increased compliance to …
One of the earliest diseases known to afflict humans, tuberculosis (TB), which is brought on by germs from the Mycobacterium tuberculosis complex, is a leading cause of death …
P Malapati, KS Vagolu, D Sriram - Biomedical and Biotechnology …, 2018 - journals.lww.com
Background: Tuberculosis (TB) still remains the leading cause of death worldwide and was unanswered till date. Available treatment strategies have many drawbacks such as longer …